RLAY - Relay Therapeutics Inc
10.69
0.550 5.145%
Share volume: 5,665,512
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$10.14
0.55
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-06-2024 | 11-06-2024 | 02-26-2025 | 05-05-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 10.007 M | 0.000 | 0.000 | 0.000 | 7.679 M | 0.000 | 6.999 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 10.007 M | 0.000 | 0.000 | 0.000 | 7.679 M | 0.000 | 6.999 M | |
| -100.00% | nan% | nan% | -100.00% | inf% | ||||
| Operating expenses | 102.202 M | 112.131 M | 96.369 M | 84.979 M | 92.548 M | 80.391 M | 67.630 M | |
| Selling general and admin | 19.799 M | 20.139 M | 19.750 M | 16.904 M | 18.739 M | 12.129 M | 12.215 M | |
| Research and development | 82.403 M | 91.992 M | 76.619 M | 68.075 M | 73.809 M | 68.262 M | 55.415 M | |
| Total expenses | 102.202 M | 100.757 M | 96.369 M | 84.979 M | 92.548 M | 80.391 M | 67.630 M | |
| -1.41% | -4.36% | -11.82% | 8.91% | -13.14% | -15.87% | |||
| Operating income | -92.195 M | -100.757 M | -96.369 M | -84.979 M | -84.869 M | -80.391 M | -60.631 M | |
| Ebit | -92.195 M | -100.759 M | -96.379 M | -84.978 M | -84.878 M | -80.556 M | -60.600 M | |
| Pretax income | -81.387 M | -92.212 M | -88.105 M | -76.004 M | -77.065 M | -74.149 M | -54.890 M | |
| 13.30% | -4.45% | -13.73% | 1.40% | -3.78% | -25.97% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -81.387 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | ||||||||
| Net income | -81.387 M | -92.212 M | -88.105 M | -76.004 M | -77.065 M | -74.149 M | -54.890 M | |
| -13.30% | 4.45% | 13.73% | -1.40% | 3.78% | 25.97% |